Related references
Note: Only part of the references are listed.Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations
Hidetoshi Hayashi et al.
CLINICAL LUNG CANCER (2022)
Artificial Intelligence-based Detection of FGFR3 Mutational Status Directly from Routine Histology in Bladder Cancer: A Possible Preselection for Molecular Testing?
Chiara Maria Lavinia Loeffler et al.
EUROPEAN UROLOGY FOCUS (2022)
Current Trend of Artificial Intelligence Patents in Digital Pathology: A Systematic Evaluation of the Patent Landscape
Muhammad Joan Ailia et al.
CANCERS (2022)
Recent Applications of Artificial Intelligence from Histopathologic Image-Based Prediction of Microsatellite Instability in Solid Cancers: A Systematic Review
Mohammad Rizwan Alam et al.
CANCERS (2022)
Recent Application of Artificial Intelligence in Non-Gynecological Cancer Cytopathology: A Systematic Review
Nishant Thakur et al.
CANCERS (2022)
Computational Analysis of Pathological Image Enables Interpretable Prediction for Microsatellite Instability
Jin Zhu et al.
FRONTIERS IN ONCOLOGY (2022)
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
Elisa Callegari et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
Korsuk Sirinukunwattana et al.
GUT (2021)
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
Abigail K. Suwala et al.
ACTA NEUROPATHOLOGICA (2021)
Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based expert system for immunohistochemistry profile interpretation
Yosep Chong et al.
DIAGNOSTIC PATHOLOGY (2021)
Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypes
James A. Diao et al.
NATURE COMMUNICATIONS (2021)
ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis
Xue-Ying Shang et al.
CELL DEATH & DISEASE (2021)
IDH-mutant gliomas with additional class-defining molecular events
Jared T. Ahrendsen et al.
MODERN PATHOLOGY (2021)
Integration of histopathological images and multi-dimensional omics analyses predicts molecular features and prognosis in high-grade serous ovarian cancer
Hao Zeng et al.
GYNECOLOGIC ONCOLOGY (2021)
Weakly supervised learning on unannotated H&E-stained slides predicts BRAF mutation in thyroid cancer with high accuracy
Deepak Anand et al.
JOURNAL OF PATHOLOGY (2021)
Predicting prognosis and IDH mutation status for patients with lower-grade gliomas using whole slide images
Shuai Jiang et al.
SCIENTIFIC REPORTS (2021)
Using deep learning to identify bladder cancers with FGFR-activating mutations from histology images
Constantine S. Velmahos et al.
CANCER MEDICINE (2021)
Artificial Intelligence Can Cut Costs While Maintaining Accuracy in Colorectal Cancer Genotyping
Alec J. Kacew et al.
FRONTIERS IN ONCOLOGY (2021)
Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine
Manish Pratap Singh et al.
GENES & DISEASES (2021)
Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Clash of the Generations
Riyaz Shah et al.
CLINICAL LUNG CANCER (2020)
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study
Ole-Johan Skrede et al.
LANCET (2020)
Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors
Maria E. Cabanillas et al.
THYROID (2020)
Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning
Amelie Echle et al.
GASTROENTEROLOGY (2020)
Current Trends of Artificial Intelligence for Colorectal Cancer Pathology Image Analysis: A Systematic Review
Nishant Thakur et al.
CANCERS (2020)
Deep learning-based classification and mutation prediction from histopathological images of hepatocellular carcinoma
Haotian Liao et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Deep learning-based cross-classifications reveal conserved spatial behaviors within tumor histological images
Javad Noorbakhsh et al.
NATURE COMMUNICATIONS (2020)
Recommendations for pathologic practice using digital pathology: consensus report of the Korean Society of Pathologists
Yosep Chong et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2020)
Prediction of clinically actionable genetic alterations from colorectal cancer histopathology images using deep learning
Hyun-Jong Jang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
A Multiple-Instance Learning-Based Convolutional Neural Network Model to Detect the IDH1 Mutation in the Histopathology Images of Glioma Tissues
Danni Cui et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2020)
The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database
Stan Benjamens et al.
NPJ DIGITAL MEDICINE (2020)
Pan-cancer image-based detection of clinically actionable genetic alterations
Jakob Nikolas Kather et al.
NATURE CANCER (2020)
Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis
Yu Fu et al.
NATURE CANCER (2020)
Introduction to digital pathology and computer-aided pathology
Soojeong Nam et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2020)
Global Evolution of Research in Artificial Intelligence in Health and Medicine: A Bibliometric Study
Bach Xuan Tran et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
Jakob Nikolas Kather et al.
NATURE MEDICINE (2019)
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
Gabriele Campanella et al.
NATURE MEDICINE (2019)
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Lawrence A. Donehower et al.
CELL REPORTS (2019)
BRAF Inhibitors in Thyroid Cancer: Clinical Impact, Mechanisms of Resistance and Future Perspectives
Fabiana Crispo et al.
CANCERS (2019)
Mapping Driver Mutations to Histopathological Subtypes in Papillary Thyroid Carcinoma: Applying a Deep Convolutional Neural Network
Peiling Tsou et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform
Cornelis Bisschop et al.
MELANOMA RESEARCH (2018)
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
Liang Cheng et al.
MODERN PATHOLOGY (2018)
Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in Melanoma
Fanny Barel et al.
ACTA DERMATO-VENEREOLOGICA (2018)
Genomics and emerging biomarkers for immunotherapy of colorectal cancer
Jakob Nikolas Kather et al.
SEMINARS IN CANCER BIOLOGY (2018)
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning
Nicolas Coudray et al.
NATURE MEDICINE (2018)
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2017)
Colon Cancer, Version 1.2017 Clinical Practice Guidelines in Oncology
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
TTK Inhibitors as a Targeted Therapy for CTNNB1 (β-catenin) Mutant Cancers
Guido J. R. Zaman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Identification of BRAF-Positive Cases Based on Whole-Slide Image Analysis
Vlad Popovici et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer
Xuxu Sun et al.
CANCER CELL (2017)
BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives
E. Sanz-Garcia et al.
ANNALS OF ONCOLOGY (2017)
Isocitrate dehydrogenase mutation as a therapeutic target in gliomas
Catherine H. Han et al.
CHINESE CLINICAL ONCOLOGY (2017)
Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Second- and third-generation ALK inhibitors for non-small cell lung cancer
Jingjing Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer
Akihiro Fujimoto et al.
NATURE GENETICS (2016)
Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification
Yu-Jie Dong et al.
ONCOLOGY LETTERS (2016)
BRAF Mutation and Thyroid Cancer Recurrence
Mingzhao Xing
JOURNAL OF CLINICAL ONCOLOGY (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Yoshinari Asaoka et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib
S. Michael Rothenberg et al.
CLINICAL CANCER RESEARCH (2015)
Genomic Portrait of Resectable Hepatocellular Carcinomas: Implications of RB1 and FGF19 Aberrations for Patient Stratification
Sung-Min Ahn et al.
HEPATOLOGY (2014)
Trastuzumab for patients with HER2 positive breast cancer: Delivery, duration and combination therapies
Ana Catarina Pinto et al.
BREAST (2013)
Genomics-Driven Oncology: Framework for an Emerging Paradigm
Levi A. Garraway
JOURNAL OF CLINICAL ONCOLOGY (2013)
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Identification of a Poor-Prognosis BRAF-Mutant-Like Population of Patients With Colon Cancer
Vlad Popovici et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma
Robert A. Soslow et al.
MODERN PATHOLOGY (2012)
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Jose Baselga et al.
LANCET (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Cancer GAMAdb: database of cancer genetic associations from meta-analyses and genome-wide association studies
Sheri D. Schully et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tissue Biomarker Development in a Multicentre Trial Context: a Feasibility Study on the PETACC3 Stage II and III Colon Cancer Adjuvant Treatment Trial
Fred T. Bosman et al.
CLINICAL CANCER RESEARCH (2009)
Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
Scott J. Rodig et al.
CLINICAL CANCER RESEARCH (2009)
Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK
Alice T. Shaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
EML4-ALK: Honing In on a New Target in Non-Small-Cell Lung Cancer
Leora Horn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Next-generation DNA sequencing
Jay Shendure et al.
NATURE BIOTECHNOLOGY (2008)
The genetics of hereditary colon cancer
Anil K. Rustgi
GENES & DEVELOPMENT (2007)
BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays
Anita L. Bane et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lièvre et al.
CANCER RESEARCH (2006)
Phenotype of microsatellite unstable colorectal carcinomas - Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability
JK Greenson et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)